Skip to main content
. 2014 Nov 19;308(2):F84–F91. doi: 10.1152/ajprenal.00274.2014

Fig. 2.

Fig. 2.

Recombinant renalase-mediated effects in Epi, NE, l-DOPA, DA, DOPAC, HVA, and 3-MT levels in plasma (A) and urine (B). Bars represent mean values ± SE, expressed as %control. *KO mice treated with recombinant renalase significantly different from corresponding values in KO mice treated with vehicle (n = 4–8).